NASDAQ:EUDA EUDA Health (EUDA) Stock Price, News & Analysis $1.46 -0.04 (-2.67%) Closing price 09/5/2025 03:56 PM EasternExtended Trading$1.47 +0.01 (+0.68%) As of 09/5/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About EUDA Health Stock (NASDAQ:EUDA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EUDA Health alerts:Sign Up Key Stats Today's Range$1.44▼$1.6950-Day Range$1.46▼$3.5852-Week Range$1.43▼$6.30Volume17,319 shsAverage Volume87,406 shsMarket Capitalization$54.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingStrong Buy Company Overview EUDA Health, Inc. (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health. EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation. These in-office treatment systems are complemented by a secure digital health platform that enables telehealth consultations, remote patient monitoring and real-time data insights for clinicians, aiming to improve patient adherence and clinical outcomes. The company distributes its devices and digital health services through a hybrid model of direct sales to healthcare practices and partnerships with established medical distributors. While its primary market is in the United States, EUDA Health has initiated market entry programs in select international regions and collaborates with clinical investigators to expand its evidence base. Led by a management team with deep experience in medical device innovation, digital therapeutics and women’s health, EUDA Health continues to pursue regulatory clearances, strategic collaborations and product enhancements. Through ongoing research and development efforts, the company aims to broaden its therapeutic offerings and further integrate its digital platform capabilities within the continuum of care.AI Generated. May Contain Errors. Read More EUDA Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreEUDA MarketRank™: EUDA Health scored higher than 10% of companies evaluated by MarketBeat, and ranked 895th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for EUDA Health.Read more about EUDA Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for EUDA Health are expected to grow in the coming year, from ($0.33) to ($0.09) per share. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.15% of the float of EUDA Health has been sold short.Short Interest Ratio / Days to CoverEUDA Health has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in EUDA Health has recently increased by 218.60%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEUDA Health does not currently pay a dividend.Dividend GrowthEUDA Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.15% of the float of EUDA Health has been sold short.Short Interest Ratio / Days to CoverEUDA Health has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in EUDA Health has recently increased by 218.60%, indicating that investor sentiment is decreasing significantly. News and Social Media2.5 / 5News Sentiment0.41 News SentimentEUDA Health has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for EUDA Health this week, compared to 1 article on an average week.MarketBeat Follows2 people have added EUDA Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EUDA Health insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 4.35% of the stock of EUDA Health is held by institutions.Read more about EUDA Health's insider trading history. Receive EUDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EUDA Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EUDA Stock News HeadlinesEUDA Health Expands into T-Cell Immunotherapy with New Malaysian PartnershipSeptember 4 at 8:57 PM | msn.comEUDA Health expands into T-cell immunotherapySeptember 4 at 3:56 PM | msn.com3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actually result in a significant loss, not gain. In fact, new reports reveal that A.I. is already driving 3 Major Threats to the global economy and your retirement. So, the sooner you take the steps to help protect yourself, the better off you will potentially be when you retire.September 6 at 2:00 AM | Goldco Precious Metals (Ad)EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy PortfolioSeptember 4 at 3:56 PM | markets.businessinsider.comHead-To-Head Survey: EUDA Health (NASDAQ:EUDA) vs. SOPHiA GENETICS (NASDAQ:SOPH)August 30, 2025 | americanbankingnews.comEUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte LtdAugust 28, 2025 | finance.yahoo.comHighly potent cannabis products tied to risk of psychosis, schizophrenia, and addiction, study findsAugust 27, 2025 | msn.comEUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health SupplementAugust 26, 2025 | markets.businessinsider.comSee More Headlines EUDA Stock Analysis - Frequently Asked Questions How have EUDA shares performed this year? EUDA Health's stock was trading at $4.47 at the start of the year. Since then, EUDA stock has decreased by 67.3% and is now trading at $1.46. Who are EUDA Health's major shareholders? Top institutional investors of EUDA Health include Hudson Bay Capital Management LP (2.14%) and Hudson Bay Capital Management LP (2.14%). How do I buy shares of EUDA Health? Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EUDA Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and iClick Interactive Asia Group (ICLK). Company Calendar Today9/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:EUDA CIK1847846 Webeuda.com Phone65-6788-0388Fax65-6788-0068Employees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.15 Sales & Book Value Annual Sales$4.01 million Price / Sales13.53 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-20.86Miscellaneous Outstanding Shares37,160,000Free FloatN/AMarket Cap$54.25 million OptionableNot Optionable Beta-0.10 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:EUDA) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
